Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome
- 11 September 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 691 (1-2) , 76-82
- https://doi.org/10.1016/0006-8993(95)00616-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Adenovirus‐mediated gene therapy of experimental gliomasJournal of Neuroscience Research, 1994
- The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in ratsJournal of Neurosurgery, 1994
- Surgical Management of Intramedullary Spinal Cord TumorsNeurosurgery, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene TherapyHuman Gene Therapy, 1993
- Thymidine kinase-mediated killing of rat brain tumorsJournal of Neurosurgery, 1993
- An experimental model of retrovirus gene therapy for malignant brain tumorsJournal of Neurosurgery, 1993
- Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of HealthHuman Gene Therapy, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Objective clinical assessment of motor function after experimental spinal cord injury in the ratJournal of Neurosurgery, 1977